Smokers with advanced colon cancer may face higher odds of disease recurrenceMay 30, 2008CHICAGO-People with advanced colon cancer who have smoked cigarettes or used other tobacco products for many years may have an increased risk that their colon cancer will return, according to research by Dana-Farber Cancer Institute scientists to be presented at the annual meeting of the American Society of Clinical Oncology (ASCO), May 30-June 3, in Chicago. Based on data from 965 patients treated for stage III colon cancer, investigators found the chances of recurrence or death up to 22 percent higher in patients with a 20 or more pack year history (calculated by number of years smoking times packs per day) than in those who had never smoked. Smoking history prior to age 30 was particularly harmful for subjects that developed colon cancer years later. Patients who smoked 12 pack years or more before age 30 and developed colon cancer later in life had a statistically significant 37 percent increase in recurrence or death compared to nonsmokers. The data (abstract 4039) will be presented during a poster session on Monday, June 2, 8 a.m. - 12 p.m. CT, South Building, Hall A1.
"After controlling for other factors that may influence the risk of colon cancer recurrence or death, this study highlights further risk of cancer recurrence in individuals who have a higher lifetime total use of cigarettes than never smokers," said lead author Nadine Jackson, MD, MPH, of Dana-Farber. Although tobacco use can increase people's initial risk of colon cancer, little is known about the short- or long-term effects of such use on disease recurrence. The current study is part of an effort to explore that issue. Participants in the study reported their tobacco use on questionnaires filled out during and six months after their treatment. Forty-five percent were identified as past smokers, 9 percent as current smokers, and 46 percent as never smokers. Dana-Farber Cancer Institute | |||||||||||||||||||||
|
Related Colon Cancer Current Events and Colon Cancer News Articles Breakthrough optical technology to assess colon cancer risk, accuracy Researchers at NorthShore University HealthSystem (NorthShore) and Northwestern University have discovered that fiber optic technology can for the very first time effectively measure blood levels in the colonic lining (mucosa) in humans, thus having potential applications for analyzing risk of colon cancer. Surgical treatment provides new option for some colorectal cancer patients Research out of Wake Forest University School of Medicine suggests that a surgical technique not traditionally used in advanced abdominal cancer may be a viable treatment option for some patients previously thought to be untreatable, offering the real possibility of extending survival for those patients. Black Americans Are At Greater Risk for Colon Polyps Black Americans have a higher occurrence of colon polyps, according to a new study. This is a significant finding considering the incidence of colon cancer among black men has increased and remained unchanged among black women during the last 20 years. Cancer-causing gut bacteria exposed Normal gut bacteria are thought to be involved in colon cancer but the exact mechanisms have remained unknown. Now, scientists from the USA have discovered that a molecule produced by a common gut bacterium activates signalling pathways that are associated with cancer cells. Brown-Assisted Trial Finds New Colorectal Screening Procedure Is Accurate and Less Invasive More patients stand to benefit from a comprehensive, less invasive method to accurately detect colorectal cancer and precancerous polyps, a multicenter study involving Brown University and institutions nationwide has found. Researchers identify cancer-causing gene in many colon cancers Demonstrating that despite the large number of cancer-causing genes already identified, many more remain to be found, scientists at Dana-Farber Cancer Institute have linked a previously unsuspected gene, CDK8, to colon cancer. '1-hit' event provides new opportunity for colon cancer prevention, say Fox Chase researchers More than 30 years ago, Alfred Knudson Jr., M.D., Ph.D., revolutionized the field of cancer genetics by showing that a person must lose both their paternal and maternal copies of a particular class of cancer-inhibiting genes, called tumor-suppressor genes, in order to develop cancer. Early stage colon cancer characterized by inactivation of gatekeeper gene The absence or inactivation of the RUNX3 gatekeeper gene paves the way for the growth and development of colon cancer, Singapore scientists report in the Sept. issue of the journal Cancer Cell. Previous studies have shown that RUNX3 plays a role in gastric, breast, lung and bladder cancers. Variation of normal protein could be key to resistance to common cancer drug Researchers at the Moores Cancer Center at the University of California, San Diego (UC SD) in La Jolla have found evidence explaining why a common chemotherapy drug, cisplatin, may not always work for every cancer patient. They have shown that when a variant version of a key protein that normally causes cell death is active, patients may be resistant to the cancer-killing drug. Anti-Cancer Flower Power Could a substance from the jasmine flower hold the key to an effective new therapy to treat cancer? More Colon Cancer Current Events and Colon Cancer News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||